В здравом уме и твердой памяти. Программа профилактики болезни Альцгеймера

Lam, L. C., et al. “Interim follow-up of a randomized controlled trial comparing Chinese style mind body (Tai Chi) and stretching exercises on cognitive function in subjects at risk of progressive cognitive decline.” Int J Geriatr Psychiatry 26 (2011): 733–40.

Irwin, M. R., et al. “Major depressive disorder and immunity to Varicella-Zoster virus in the elderly.” Brain Behav Immun 25 (2011): 759–66.

Stein, M. B., et al. “A prospective community study of adolescents and young adults.” Arch Gen Psychiatry 58 (2001): 251–56.

Bryant, C., et al. “The prevalence of anxiety in older adults: Methodological issues and a review of the literature.” J Aff Disord 109 (2008): 233–50.

Goldin, P. R., et al. “The neural bases of amusement and sadness: a comparison of block contrast and subject-specific emotion intensity regression approaches.” Neuroimage 27 (2005): 26–36.

Leichsenring, F., and S. Rabung. “Effectiveness of long-term psychodynamic psychotherapy: a metaanalysis.” JAMA 300 (2008): 1551–65.

Глава 8

Alzheimer’s Foundation of America Survey. “Americans with Memory Concerns Fall Short of Talking to Doctors.” http://www.alzfdn.org/MediaCenter/073008.html.

Fox, S. “Online health search 2006.” Pew Internet & American Life Project. October 29, 2006. www.pewinternet.org/Reports/ 2006/Online-Health-Search-2006.aspx.

Kasper, J., et al. “Turning signals into meaning: ‘Shared decision making’ meets communication theory.” Health Expect 2011. doi: 10.1111/j.1369–7625.2011.00657.x.

Elwyn, G., et al. “Achieving involvement: process outcomes from a cluster randomized trial of shared decision making skill development and use of risk communication aids in general practice.” Fam Pract 21 (2004): 337–46.

Schwartz, E., et al. “Cardiovascular risk factors affect hippocampal microvasculature in early AD.” Transl Neurosci 1 (2010): 292–99.

Braskie, M. N., et al. “Vascular health risks and fMRI activation during a memory task in older adults.” Neurobiol Aging 31 (2010): 1532–42.

Godin, O., et al. “Antihypertensive treatment and change in blood pressure are associated with the progression of white matter lesion volumes: the Three-City (3C)-Dijon Magnetic Resonance Imaging Study.” Circulation. 123 (2011): 266–73.

Li, J., et al. “Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease.” Neurology 76 (2011): 1485–91.

Lin, F. R., et al. “Hearing loss and incident dementia.” Arch Neurol. 68 (2011): 214–20.

Reitz, C., et al. “Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of lateonset Alzheimer disease.” Arch Neurol 67 (2010): 1491–97.

Bettermann, K., et al. “Statins, risk of dementia, and cognitive function: Secondary analysis of the Ginkgo Evaluation of Memory Study.” J Stroke Cerebrovasc Dis 12 Jan 2011.website TK

De Felice, F. G., et al. “Protection of synapses against Alzheimer’s-linked toxins: Insulin signaling prevents the pathogenic binding of A_ oligomers.” Proc Natl Acad Sci USA 106 (2009): 1971–76.

Szekely, C. A., et al. “No Advantage of A_42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies.” Neurology 70 (2008): 2291–98.

Small, G. W., and L. F. Jarvik. “The dementia syndrome.” Lancet 2 (1982): 1443–46.

Radimer, K., et al. “Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999–2000.” Am J Epidemiol 160 (2004): 339–49.

Small, G. W. “Beyond standard anti-dementia therapies: Diet, exercise, socialization, and supplements: CNS Spectrums 13 (Suppl 16) (2008): 31–33

Usharani, P., et al. “Effect of NCB-02, atorvastatin and placebo on endothelial function, oxidative stress and inflammatory markers in patients with type 2 diabetes mellitus: a randomized, parallel-group, placebo-controlled, 8-week study.” Drugs R D 9 (2008): 243–50.

Hubbard, W. K. “Letter updating the phosphatidylserine and cognitive function and dementia qualified health claim.” FDA U.S. Department of Health and Human Services. November 24, 2004. http://www.fda.gov/Food/LabelingNutrition/LabelClaims/QualifiedHealth- Claims/ucm072993.htm.

Vakhapova, V., et al. “Phosphatidylserine containing omega-3 fatty acids may improve memory abilities in nondemented elderly with memory complaints: a double-blind placebo-controlled trial.” Dement Geriatr Cogn Disord 29 (2010): 467–74.

Kato-Kataoka, A., et al. “Soybean-derived phosphatidylserine improves memory function of the elderly Japanese subjects with memory complaints.” J Clin Biochem Nutr 47 (2010): 246–55.

Honein, M. A., et al. “Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects.” JAMA 285 (2001): 2981–86.